Literature DB >> 9144588

Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary.

H Lignelid1, V P Collins, B Jacobsson.   

Abstract

The localization of cystatin C (CC) and transthyretin (TTR) synthesis was studied using Northern blot and immunohistochemical methods. Normal brain tissues from all sites studied contained CC mRNA. Immunoreactive CC was present in the choroid plexus epithelial cells, cerebral and cerebellar neurons, astrocytes, ependymal cells, macrophage-like cells of the arachnoid membrane and in neuroendocrine cells of the anterior pituitary lobe. TTR mRNA and TTR were restricted to the choroid plexus. In primary brain tumors, the transcript for CC was found in all 39 tumors examined, while the protein could only be demonstrated in 3/5 choroid plexus papillomas, 8/8 astrocytomas, 7/23 anaplastic astrocytomas and glioblastomas, 1/6 oligodendrogliomas, 1/1 oligoastrocytoma, 1/4 anaplastic oligodendrogliomas, 3/7 ependymomas, 0/1 anaplastic ependymoma, 0/5 primitive neuroectodermal tumors, 0/1 neuroblastoma, 3/11 meningiomas and 16/16 pituitary adenomas. CC cannot be used as a marker for any specific brain tumor type but the fact that the protein could be demonstrated more frequently in astrocytomas than in their more malignant counterparts suggests that the cellular production and secretion of CC changes with the malignant progression of these tumors. TTR mRNA and TTR were present only in the choroid plexus papillomas, indicating that TTR synthesis is mainly restricted to such brain neoplasms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144588     DOI: 10.1007/s004010050644

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  The choroid plexus removes beta-amyloid from brain cerebrospinal fluid.

Authors:  Janelle S Crossgrove; G Jane Li; Wei Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2005-11

Review 2.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

3.  Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers.

Authors:  Janelle S Crossgrove; Ellen L Smith; Wei Zheng
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

4.  Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid.

Authors:  J Sajanti; K Majamaa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

5.  Induced expression of cathepsins and cystatin C in a murine model of demyelination.

Authors:  Jianmei Ma; Kenji F Tanaka; Gen Yamada; Kazuhiro Ikenaka
Journal:  Neurochem Res       Date:  2006-11-04       Impact factor: 3.996

6.  Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.

Authors:  Boris Gole; María Beatriz Durán Alonso; Vincenc Dolenc; Tamara Lah
Journal:  Pathol Oncol Res       Date:  2009-05-13       Impact factor: 3.201

7.  Cystatin C has a dual role in post-traumatic brain injury recovery.

Authors:  Marina Martinez-Vargas; Maribel Soto-Nuñez; Erika Tabla-Ramon; Barbara Solis; Ruben Gonzalez-Rivera; Adan Perez-Arredondo; Francisco Estrada-Rojo; Andres Castell; Juan Molina-Guarneros; Luz Navarro
Journal:  Int J Mol Sci       Date:  2014-04-04       Impact factor: 5.923

Review 8.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

9.  Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model.

Authors:  John C Whitin; Taichang Jang; Milton Merchant; Tom T-S Yu; Kenneth Lau; Benjamin Recht; Harvey J Cohen; Lawrence Recht
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

10.  Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis.

Authors:  P Strojan; I Oblak; B Svetic; L Smid; J Kos
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.